Market revenue in 2023 | USD 34.7 million |
Market revenue in 2030 | USD 46.6 million |
Growth rate | 4.3% (CAGR from 2023 to 2030) |
Largest segment | Oncology |
Fastest growing segment | Infectious Diseases |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Infectious Diseases, Immunology, Oncology, Stem Cells, Neurobiology |
Key market players worldwide | Abcam PLC, Merck KGaA, Thermo Fisher Scientific Inc, Becton Dickinson & Co, Bio-Techne Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mice based research antibody market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 30.84% in 2023. Horizon Databook has segmented the Latin America mice based research antibody market based on infectious diseases, immunology, oncology, stem cells, neurobiology covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America mice based research antibody market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America mice based research antibody market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account